Alimera Sciences
在场
Alimera Sciences 的所有者是 ANI Pharmaceuticals.
是其中之一......
ANI Pharmaceuticals 是一家在股票代码 ANIP (US) 下上市的公司。
他们在：
涉及ANI Pharmaceuticals的并购和融资。
- ANI Pharmaceuticals 已收购 Alimera Sciences (公布2024九月16号).
- ANI Pharmaceuticals has announced the acquisition of Alimera Sciences (公布2024六月26号).
高管
查看带有其 15 名主要高管的组织结构图
Alimera Sciences 搜索最多的简介
- Rick Eiswirth, President, Chief Executive Officer and Director
- Maggie Pax, Director
- Erin Parsons, Director
创建提醒
跟踪 Alimera Sciences 的高管变动
药店
ANI Pharmaceuticals 拥有 1,840 家竞争者，其中包括 Pfizer (美国(美洲))、Johnson & Johnson (美国(美洲)) 和 Sanofi (法国)。
Popular M&A news in 药店
- Recursion Pharma and Exscientia have merged (公布2024十一月27号)..
- Stemtech and Seacret Direct have announced they will merge (公布2024十一月22号)..
- BeiGene将改名为BeOne Medicines。 (公布2024十一月15号).
药店 行业的其他推荐联系人
消息
Alimera Sciences 的最新新闻稿
- Press Releases | Alimera Sciences Inc.
- Alimera Sciences Reports Record Fourth Quarter and 2019 Results | Alimera Sciences
- Alimera Sciences Meets Revenue Milestone and Accesses Additional $2.5 Million Under Solar Debt Agreement | Alimera Sciences
- Alimera Sciences to Report Fourth Quarter and Full Year 2019 Financial Results on Wednesday, February 26, 2020 and Provide Corporate Update | Alimera Sciences
- Alimera Sciences Refinances Its Debt Facility With Solar Capital | Alimera Sciences
- Alimera Sciences to Participate in the LD Micro 12th Annual Main Event on December 10, 2019 | Alimera Sciences
- Press Releases | Investor Relations | Alimera Sciences
- Alimera Sciences to Participate in the LD Micro 12th Annual Main Event on December 10, 2019 | Alimera Sciences
- Alimera Announces Regulatory Approval for ILUVIEN® in Benelux Countries for The Treatment of Non-Infectious Posterior Uveitis | Alimera Sciences
- Alimera Sciences Announces Effectiveness of Previously Announced Reverse Stock Split | Alimera Sciences
- View more press releases Close
通过电子邮件
